Trenzyme Licenses SEFEX Cell Line Technology from Celonic AG

News   Oct 09, 2015

 
Trenzyme Licenses SEFEX Cell Line Technology from Celonic AG
 
 
 

RELATED ARTICLES

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

Novel Scaffolds to Grow Muscle Developed

News

RMIT biomedical engineers have successfully produced a 3D material that mimics nature to transform cells into muscle.

READ MORE

Researchers Discover Key Link Between Mitochondria and Cocaine Addiction

News

Researchers were able to block response in mitochondria to cocaine.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE